Altered mitochondrial regulation in quadriceps muscles of patients with COPD
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Altered mitochondrial regulation in quadriceps muscles of patients with COPD. / Naimi, Ashley I; Bourbeau, Jean; Perrault, Helene; Baril, Jacinthe; Wright-Paradis, Cynthia; Rossi, Amanda; Taivassalo, Tanja; Sheel, A William; Rabøl, Rasmus; Dela, Flemming; Boushel, Robert Christopher.
In: Clinical Physiology and Functional Imaging, Vol. 31, No. 2, 2011, p. 124-31.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Altered mitochondrial regulation in quadriceps muscles of patients with COPD
AU - Naimi, Ashley I
AU - Bourbeau, Jean
AU - Perrault, Helene
AU - Baril, Jacinthe
AU - Wright-Paradis, Cynthia
AU - Rossi, Amanda
AU - Taivassalo, Tanja
AU - Sheel, A William
AU - Rabøl, Rasmus
AU - Dela, Flemming
AU - Boushel, Robert Christopher
N1 - © 2010 The Authors. Clinical Physiology and Functional Imaging © 2010 Scandinavian Society of Clinical Physiology and Nuclear Medicine.
PY - 2011
Y1 - 2011
N2 - Evidence exists for locomotor muscle impairment in patients with chronic obstructive pulmonary disease (COPD), including fiber type alterations and reduced mitochondrial oxidative capacity. In this study high-resolution respirometry was used to quantify oxygen flux in permeabilized fibres from biopsies of the vastus lateralis muscle in patients with COPD and compared to healthy control subjects. The main findings of this study were that (i) routine state 2 respiration was higher in COPD; (ii) state 3 respiration in the presence of ADP was similar in both groups with substrate supply of electrons to complex I (COPD 38·28 ± 3·58 versus control 42·85 ± 3·10 pmol s(-1) mg tissue(-1) ), but O(2) flux with addition of succinate was lower in COPD patients (COPD 63·72 ± 6·33 versus control 95·73 ± 6·53 pmol s(-1) mg tissue(-1) ); (iii) excess capacity of cytochrome c oxidase in COPD patients was only ~50% that of control subjects. These results indicate that quadriceps muscle mitochondrial function is altered in patients with COPD. The regulatory mechanisms underlying these functional abnormalities remain to be uncovered.
AB - Evidence exists for locomotor muscle impairment in patients with chronic obstructive pulmonary disease (COPD), including fiber type alterations and reduced mitochondrial oxidative capacity. In this study high-resolution respirometry was used to quantify oxygen flux in permeabilized fibres from biopsies of the vastus lateralis muscle in patients with COPD and compared to healthy control subjects. The main findings of this study were that (i) routine state 2 respiration was higher in COPD; (ii) state 3 respiration in the presence of ADP was similar in both groups with substrate supply of electrons to complex I (COPD 38·28 ± 3·58 versus control 42·85 ± 3·10 pmol s(-1) mg tissue(-1) ), but O(2) flux with addition of succinate was lower in COPD patients (COPD 63·72 ± 6·33 versus control 95·73 ± 6·53 pmol s(-1) mg tissue(-1) ); (iii) excess capacity of cytochrome c oxidase in COPD patients was only ~50% that of control subjects. These results indicate that quadriceps muscle mitochondrial function is altered in patients with COPD. The regulatory mechanisms underlying these functional abnormalities remain to be uncovered.
KW - Adenosine Diphosphate
KW - Aged
KW - Biopsy
KW - Case-Control Studies
KW - Cell Respiration
KW - Denmark
KW - Electron Transport Chain Complex Proteins
KW - Electron Transport Complex IV
KW - Energy Metabolism
KW - Humans
KW - Lung
KW - Male
KW - Middle Aged
KW - Mitochondria, Muscle
KW - Oxygen Consumption
KW - Pulmonary Disease, Chronic Obstructive
KW - Quadriceps Muscle
KW - Respiratory Function Tests
KW - Succinic Acid
U2 - 10.1111/j.1475-097X.2010.00988.x
DO - 10.1111/j.1475-097X.2010.00988.x
M3 - Journal article
C2 - 21091605
VL - 31
SP - 124
EP - 131
JO - Clinical Physiology and Functional Imaging
JF - Clinical Physiology and Functional Imaging
SN - 1475-0961
IS - 2
ER -
ID: 33815758